Onkos Diagnósticos Moleculares
PrivateLast Round
Grant
May 1, 2025
Company Overview
Onkos Diagnósticos Moleculares is a biotechnology company that develops molecular diagnostic tests for oncology, specializing in gene expression profiling and genetic markers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Onkos Diagnósticos Moleculares Comparables
Compare Onkos Diagnósticos Moleculares with similar companies based on industry and business-model similarity.
Onkos Diagnósticos Moleculares Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 1, 2025 | ||||
| Accelerator | Nov 1, 2018 |
Onkos Diagnósticos Moleculares Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Eretz.bio | Accelerator |
| Conselho Nacional de Desenvolvimento Científico e Tecnológico | Grant |
| Financiadora de Estudos e Projetos | Grant |
| SUPERA Parque de Inovação e Tecnologia | Accelerator |
| FAPESP | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 2, 2025
Grew 25% QoQ, from 32 to 40 employees.
- May 13, 2025
Grew 15% QoQ, from 33 to 38 employees.
Onkos Diagnósticos Moleculares Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Onkos Diagnósticos Moleculares's valuation, stock price, and market status.
Is Onkos Diagnósticos Moleculares a public or private company?
Onkos Diagnósticos Moleculares is a private company.
What is the current stock price of Onkos Diagnósticos Moleculares?
Onkos Diagnósticos Moleculares is a private company with no public stock price. Caplight tracks Onkos Diagnósticos Moleculares's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Onkos Diagnósticos Moleculares worth (valuation)?
Valuation information for Onkos Diagnósticos Moleculares is not publicly available.
Can I buy Onkos Diagnósticos Moleculares stock?
Onkos Diagnósticos Moleculares shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Onkos Diagnósticos Moleculares's last funding round?
Onkos Diagnósticos Moleculares's most recent funding round was Grant on May 1, 2025.
Who are the main investors in Onkos Diagnósticos Moleculares?
Key investors in Onkos Diagnósticos Moleculares include Eretz.bio, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Financiadora de Estudos e Projetos, SUPERA Parque de Inovação e Tecnologia, FAPESP.
Will Onkos Diagnósticos Moleculares IPO soon?
No public IPO plans have been announced for Onkos Diagnósticos Moleculares.
How can I track Onkos Diagnósticos Moleculares secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Onkos Diagnósticos Moleculares's secondary market activity and sign up for updates.